The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
64
Participants will come in person and receive a one time 60 mg dose by mouth.
Participants will come in person and receive a one time 60 mg placebo pill dose by mouth.
University of Miami
Miami, Florida, United States
RECRUITINGTotal Milligram Morphine Equivalent (MME)
The primary outcome measure was milligram morphine equivalent units to measure pain intensity difference and total pain relief
Time frame: Up to 24 hours
Change in Pain as measured by Visual Analog Scale (VAS)
The VAS used for pain assessment consists of a line drawn in the form of a ruler, and numbers from 0 to 10 (with 0 as "no pain" and 10 as "unbearable pain") were asked to score.
Time frame: Baseline, up to 24 hours, 3 months
Musculoskeletal function as measured by SMFA questionnaire
The Short Musculoskeletal Function Assessment Questionnaire (SMFA) consists of 34 questions covering the assessment of the patients function and 12 questions related to how bothered patients are by their symptoms. All categories are scored together, totaling between 0-100 percent. The lower the score, the better the subject's function
Time frame: Up to 3 months
Hospital Length of stay measured in hours
Hospital Length of stay measured in hours
Time frame: Up to 96 hours
Ambulation distance measured by meters
Ambulation distance measured by meters
Time frame: Up to 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.